You are viewing United States

Neumentix™ Illuminates New Frontiers in Neural Tissue Support

Posted December 19, 2023

Kemin Industries, a leading nutritional ingredients supplier committed to transforming lives through sustainable products and services, is thrilled to share groundbreaking findings from our latest study on Neumentix™.

Published in the November 2023 issue of Translational Vision Science & Technology (TVST), this research, co-authored by the University of Pisa and Kemin, explores the efficacy of our nootropic, Neumentix in providing nutritional support for neural tissues outside the brain through a rat model of hypertensive glaucoma. In this blog post, we'll delve into the study's key insights, specifically for the nutraceutical industry, and explore the potential opportunities for supplement manufacturers.

Key Findings:

  1. Preservation of Retinal Ganglion Cells Health & Function: Our study demonstrates that the oral intake of Neumentix plays a crucial role in preserving the activity and viability of retinal ganglion cells in a rat model of hypertensive glaucoma. This exciting discovery suggests a potential avenue for Neumentix in supporting eye health.
  2. Mechanisms of Action Beyond the Brain: Neumentix showcases its mechanisms beyond the brain, proving effective action on neural tissues in the eyes. This expands the potential applications of Neumentix in addressing common degenerative pathways affecting both the eyes and the brain.
  3. Antioxidant and Neuroprotective Effects: Dr. Rosario Amato underscores Neumentix's intraocular pressure (IOP)-independent antioxidant, neuroprotective and neuroprotective effects. This is particularly significant for managing glaucoma, a condition influenced by oxidative stress, inflammation, and lack of neural trophic support.
  4. Modulation of Neuroprotective Mechanisms: Our study reveals that Neumentix dose-dependently modulates neuroprotective mechanisms, offering a promising avenue for countering the drivers of neurodegeneration in retinal ganglion cells.

Opportunities for Supplement Manufacturers:

  1. Formulation Opportunities: Manufacturers can explore eye health solutions that transcend the eyes’ light-capturing function, addressing the complex neural tissues linking the eye and brain with the integration of Neumentix.
  2. Educational Marketing: Leverage the careful selection of Neumentix in your formula backed by the scientific power of 20 peer-reviewed scientific publications. Educate consumers about its benefits in supporting both eye and brain health.
  3. Diversification of Product Lines: Consider expanding product lines to incorporate Neumentix for its cognitive and physical performance benefits. Highlight its relevance for both the eyes and the brain in helping to adapt to physiological changes or insults.
  4. Quality Assurance: Use product that adheres to rigorous testing and quality control measures to guarantee the purity and potency of Neumentix in formulations. This ensures finish products transparently communicate the scientific support for its effectiveness.

At Kemin, we are proud to present Neumentix as an innovative botanical ingredient with opportunities for neural health, extending beyond the brain to provide support for eye health. Supplement manufacturers in the nutraceutical industry have a unique opportunity to capitalize on these findings by incorporating Neumentix into formulations designed to address the multifaceted challenges of neural tissue health. This breakthrough positions Neumentix as a key player in the pursuit of innovative nutritional solutions for age-related changes in both the eyes and the brain.

Subscribe to our Blog


These statements have not been evaluated by the US Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

The information on this webpage is a business-to-business information and not intended for the final consumer. Certain statements may not be applicable in all geographical regions. Product labeling and associated claims differs based upon government requirements and country or region specific information should also be considered when labeling or advertising to final consumers.

This web page and its associated brochures and other documents do not constitute or provide scientific or medical advice, diagnosis, or treatment and are distributed without warranty of any kind, either expressly or implied. This web page, its title or contents and associated brochures and other documents do not in any way make recommendations for health or marketing claims by the reader. Country and region specific regulations should be considered in this regard. Each claim or statement about the effectiveness of Kemin products and/or each claim or statement comparing the effectiveness of Kemin products to the effectiveness of other products is expressly limited to the United States, unless otherwise disclosed on the Kemin websites.